Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02854358Phase 2Completed
Phase 2, randomised, open-label trial of alcea digitata and mallow extract in xerostomia (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Quality of Life at 4 weeks. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02854358.